Jincheng Song
Overview
Explore the profile of Jincheng Song including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin X, Zhu J, Song J, Wang L, Ge J, Sha W
Global Spine J
. 2024 Nov;
:21925682241297934.
PMID: 39504264
Study Design: Retrospective Study. Objectives: The selection of floating fusion or lumbosacral fusion arises when treating patients with instability or stenosis of the lower lumbar spine concomitantly radiographic degeneration of...
2.
Zhao J, Hassani M, Song J, Sun X
J Pediatr Hematol Oncol
. 2024 Sep;
46(7):375-379.
PMID: 39324884
Objective: The objective of this research is to examine the therapy and outlook of pediatric primary central nervous system Burkitt lymphomas. Methods: This study involves a retrospective analysis of the...
3.
Li D, Zhu Y, Song J, Yang D, Cui S, Liu X, et al.
Front Oncol
. 2024 May;
14:1339511.
PMID: 38699646
The management of non-small cell lung cancer (NSCLC), specifically targeting the anaplastic lymphoma kinase () with tyrosine kinase inhibitors (TKIs), is challenged by the emergence of therapeutic resistance. Resistance mechanisms...
4.
Zhao X, Xu M, Hu X, Ding X, Zhang X, Xu L, et al.
Stem Cell Res Ther
. 2023 May;
14(1):148.
PMID: 37248542
Background: Exosomes play important roles in intercellular communication by delivering microRNAs (miRNAs) that mediate tumor initiation and development, including those in diffuse large B cell lymphoma (DLBCL). To date, however,...
5.
Che Y, Xu L, Zhang X, Qiu X, Song J, Ding X, et al.
Clin Case Rep
. 2022 Nov;
10(11):e6528.
PMID: 36415711
Hemophagocytic lymphohistiocytosis (HLH) is a severe syndrome of pathological immune activation caused by activated macrophages and cytotoxic T cells. We report a 65-year-old male Chinese patient with typical HLH features...
6.
Huang Q, Gu Q, Song J, Yan F, Lin X
Front Surg
. 2022 Aug;
9:975681.
PMID: 36017524
Objective: To analyze the effect of percutaneous endoscopic lumbar discectomy in treating lumbar intervertebral infections. Methods: A total of 13 patients with lumbar intervertebral infections who underwent percutaneous endoscopic lumbar...
7.
Zou D, Song J, Deng M, Ma Y, Yang C, Liu J, et al.
FASEB J
. 2021 Apr;
35(5):e21601.
PMID: 33913201
Peritoneal dissemination threatens the survival of patients with gastric cancer (GC). Bufalin is an extract of traditional Chinese medicine, which has been proved to have anticancer effect. The target of...
8.
Zou D, Li Z, Lv F, Yang Y, Yang C, Song J, et al.
Front Oncol
. 2021 Mar;
11:592761.
PMID: 33747912
(endothelial NOS, ) is a member of the nitric oxide synthase (NOS) enzyme family, mainly participating in nitric oxide (NO) generation. has been reported to inhibit apoptosis and promote angiogenesis,...
9.
Zhang X, Zhao X, Liu K, Che Y, Qiu X, Qu Y, et al.
Am J Chin Med
. 2020 Nov;
48(7):1633-1650.
PMID: 33148004
Bufalin is an anticancer drug extract from traditional Chinese medicine. Several articles about bufalin have been published. However, the literature on bufalin has not yet been systematically studied. This study...
10.
Song J, Zou D, Zhao X, Chen Y, Lv F, Wang S, et al.
Carcinogenesis
. 2020 Oct;
42(2):303-314.
PMID: 33124657
The 5-year survival rate of diffuse large B-cell lymphoma (DLBCL) can reach 60%. However, nearly half of patients undergo relapse/refractory issues with a survival period of less than 2 years....